The Increasing Role of Real-World Trials in Vascular Research

Speaker(s)

• 

  Michael Jaff, DO

  Professor of Medicine (retired)
  Harvard Medical School
  Vascular Medicine
  Maple Grove, Minnesota, United States

  Disclosure(s): Access Vascular: Stockholder - Privately-held company
  Boston Scientific: Employee; Stockholder - Publicly-traded company (excludes mutual/index funds)
  Efemoral: Stockholder - Privately-held company
  Embolitech: Stockholder - Privately-held company
  Gilde Healthcare: Consultant
  Healthcare InRoads: Owner/Co-Owner, or Founder/Co-Founder
  Heartbeam: Stockholder - Publicly-traded company (excludes mutual/index funds)
  Janacare: Stockholder - Privately-held company
  Nectero: Stockholder - Privately-held company
  Primacea: Owner/Co-Owner, or Founder/Co-Founder
  R3 Vascular: Stockholder - Privately-held company